Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (otvara se novi prozor)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

Izvor‎: J Bone Joint Surg Am 2013;95(21):1969-74.

Indeks‎: PubMed 24196467

DOI‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (otvara se novi prozor)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (otvara se novi prozor)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

Izvor‎: J Bone Joint Surg Am 2013;95(21):1961-8.

Indeks‎: PubMed 24196466

DOI‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (otvara se novi prozor)

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (otvara se novi prozor)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

Izvor‎: Ann Surg 2019;269(5):794-804.

Indeks‎: PubMed 30418206

DOI‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (otvara se novi prozor)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (otvara se novi prozor)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

Izvor‎: Spine 2009;34(19):2096-103.

Indeks‎: PubMed 19730217

DOI‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (otvara se novi prozor)

The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (otvara se novi prozor)

Cankaya D, Dasar U, Satilmis AB, Basaran SH, Akkaya M, Bozkurt M.

Izvor‎: J Orthop Surg 2017;25(1):2309499016684725.

Indeks‎: PubMed 28176599

DOI‎: 10.1177/2309499016684725

https://www.ncbi.nlm.nih.gov/pubmed/28176599 (otvara se novi prozor)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (otvara se novi prozor)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

Izvor‎: J Arthroplasty 2013;28(8 Suppl):74-7.

Indeks‎: PubMed 24034510

DOI‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (otvara se novi prozor)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (otvara se novi prozor)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Izvor‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Indeks‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (otvara se novi prozor)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (otvara se novi prozor)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

Izvor‎: J Knee Surg 2017;30(5):460-6.

Indeks‎: PubMed 27699724

DOI‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (otvara se novi prozor)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (otvara se novi prozor)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

Izvor‎: J Arthroplasty 2017;32(8):2375-80.

Indeks‎: PubMed 28343823

DOI‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (otvara se novi prozor)

Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (otvara se novi prozor)

DiBlasi JF, Smith RP, Garavaglia J, Quedado J, Frye BM, Dietz MJ.

Izvor‎: Am J Orthop 2016;45(7):E439-43.

Indeks‎: PubMed 28005108

https://www.ncbi.nlm.nih.gov/pubmed/28005108 (otvara se novi prozor)

Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (otvara se novi prozor)

Dobosz B, Dutka J, Dutka L, Maleta P.

Izvor‎: Ortop Traumatol Rehabil 2012;14(5):421-8.

Indeks‎: PubMed 23208933

DOI‎: 10.5604/15093492.1016367

https://www.ncbi.nlm.nih.gov/pubmed/23208933 (otvara se novi prozor)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (otvara se novi prozor)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

Izvor‎: Spine J 2017;17(7):977-82.

Indeks‎: PubMed 28323241

DOI‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (otvara se novi prozor)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (otvara se novi prozor)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Izvor‎: Orthop Clin North Am 2017;48(2):109-15.

Indeks‎: PubMed 28336035

DOI‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (otvara se novi prozor)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (otvara se novi prozor)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

Izvor‎: Ir Med J 2018;111(4):730.

Indeks‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (otvara se novi prozor)

Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (otvara se novi prozor)

Frank SM, Pippa A, Sherd I, Scott AV, Lo BD, Cruz NC, Hendricks EA, Ness PM, Chaturvedi S, Resar LMS.

Izvor‎: Anesth Analg 2022;135(3):576-85.

Indeks‎: PubMed 35977366

DOI‎: 10.1213/ANE.0000000000006114

https://www.ncbi.nlm.nih.gov/pubmed/35977366 (otvara se novi prozor)

Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (otvara se novi prozor)

Frank SM, Wasey JO, Dwyer IM, Gokaslan ZL, Ness PM, Kebaish KM.

Izvor‎: J Orthop Surg Res 2014;9:50.

Indeks‎: PubMed 24997589

DOI‎: 10.1186/s13018-014-0050-2

https://www.ncbi.nlm.nih.gov/pubmed/24997589 (otvara se novi prozor)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (otvara se novi prozor)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

Izvor‎: J Shoulder Elbow Surg 2016;25(4):614-8.

Indeks‎: PubMed 26652697

DOI‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (otvara se novi prozor)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (otvara se novi prozor)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

Izvor‎: Transfusion 2017;57(2):357-66.

Indeks‎: PubMed 28019009

DOI‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (otvara se novi prozor)

Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (otvara se novi prozor)

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, Sierra RJ.

Izvor‎: J Arthroplasty 2013;28(8 Suppl):137-9.

Indeks‎: PubMed 23886409

DOI‎: 10.1016/j.arth.2013.04.054

https://www.ncbi.nlm.nih.gov/pubmed/23886409 (otvara se novi prozor)

Cell saver for adult spinal deformity surgery reduces cost. (otvara se novi prozor)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

Izvor‎: Spine Deform 2017;5(4):272-6.

Indeks‎: PubMed 28622903

DOI‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (otvara se novi prozor)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (otvara se novi prozor)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

Izvor‎: J Am Acad Orthop Surg 2021;29(22):961-9.

Indeks‎: PubMed 34570739

DOI‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (otvara se novi prozor)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (otvara se novi prozor)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

Izvor‎: Orthopedics 2017;40(6):e1044-9.

Indeks‎: PubMed 28968480

DOI‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (otvara se novi prozor)

Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (otvara se novi prozor)

Harris RN, Moskal JT, Capps SG.

Izvor‎: J Arthroplasty 2015;30(2):192-5.

Indeks‎: PubMed 25534861

DOI‎: 10.1016/j.arth.2014.08.020

https://www.ncbi.nlm.nih.gov/pubmed/25534861 (otvara se novi prozor)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (otvara se novi prozor)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Izvor‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Indeks‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (otvara se novi prozor)

Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (otvara se novi prozor)

Karayiannis PN, Agus A, Bryce L, Hill JC, Beverland D.

Izvor‎: Bone Jt Open 2022;3(7):536-42.

Indeks‎: PubMed 35816170

DOI‎: 10.1302/2633-1462.37.BJO-2021-0213.R1

https://www.ncbi.nlm.nih.gov/pubmed/35816170 (otvara se novi prozor)

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (otvara se novi prozor)

Kotzé A, Carter LA, Scally AJ.

Izvor‎: Br J Anaesth 2012;108(6):943-52.

Indeks‎: PubMed 22593128

DOI‎: 10.1093/bja/aes135

https://www.ncbi.nlm.nih.gov/pubmed/22593128 (otvara se novi prozor)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (otvara se novi prozor)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Izvor‎: Transfusion 2017;57(6):1347-58.

Indeks‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (otvara se novi prozor)

Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (otvara se novi prozor)

Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D.

Izvor‎: Br J Anaesth 2007;99(6):794-800.

Indeks‎: PubMed 17928302

DOI‎: 10.1093/bja/aem266

https://www.ncbi.nlm.nih.gov/pubmed/17928302 (otvara se novi prozor)

A safe, simple and cost-effective protocol for blood transfusion in primary total knee replacement. (otvara se novi prozor)

Mehra A, Murray J, DeAlwis C.

Izvor‎: Ann R Coll Surg Engl 2004;86(4):260-2.

Indeks‎: PubMed 15239867

DOI‎: 10.1308/147870804551

https://www.ncbi.nlm.nih.gov/pubmed/15239867 (otvara se novi prozor)

Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (otvara se novi prozor)

Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, Delanois RE.

Izvor‎: J Arthroplasty 2018;33(6):1705-12.

Indeks‎: PubMed 29352682

DOI‎: 10.1016/j.arth.2017.12.014

https://www.ncbi.nlm.nih.gov/pubmed/29352682 (otvara se novi prozor)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (otvara se novi prozor)

Moskal JT, Harris RN, Capps SG.

Izvor‎: J Arthroplasty 2015;30(3):365-8.

Indeks‎: PubMed 25458093

DOI‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (otvara se novi prozor)

The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (otvara se novi prozor)

Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J.

Izvor‎: Blood Transfus 2013;11(2):260-71.

Indeks‎: PubMed 23149145

DOI‎: 10.2450/2012.0139-12

https://www.ncbi.nlm.nih.gov/pubmed/23149145 (otvara se novi prozor)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (otvara se novi prozor)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

Izvor‎: Blood Transfus 2014;12(1):40-9.

Indeks‎: PubMed 24120595

DOI‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (otvara se novi prozor)

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. (otvara se novi prozor)

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH.

Izvor‎: Transfusion 2011;51(1):118-24.

Indeks‎: PubMed 20624257

DOI‎: 10.1111/j.1537-2995.2010.02783.x

https://www.ncbi.nlm.nih.gov/pubmed/20624257 (otvara se novi prozor)

Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures. (otvara se novi prozor)

Nichols CI, Vose JG.

Izvor‎: J Arthroplasty 2016;31(3):583-589.e1.

Indeks‎: PubMed 26699673

DOI‎: 10.1016/j.arth.2015.10.013

https://www.ncbi.nlm.nih.gov/pubmed/26699673 (otvara se novi prozor)

The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (otvara se novi prozor)

Örs Ç, Çaylak R.

Izvor‎: Acta Orthop Traumatol Turc 2021;55(5):422-7.

Indeks‎: PubMed 34730529

DOI‎: 10.5152/j.aott.2021.20397

https://www.ncbi.nlm.nih.gov/pubmed/34730529 (otvara se novi prozor)

Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (otvara se novi prozor)

Ortega-Andreu M, Pérez-Chrzanowska H, Figueredo R, Gómez-Barrena E.

Izvor‎: Open Orthop J 2011;5:44-8.

Indeks‎: PubMed 21552468

DOI‎: 10.2174/1874325001105010044

https://www.ncbi.nlm.nih.gov/pubmed/21552468 (otvara se novi prozor)

ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (otvara se novi prozor)

Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J.

Izvor‎: Anesth Analg 2022;135(3):448-58.

Indeks‎: PubMed 35977355

DOI‎: 10.1213/ANE.0000000000006065

https://www.ncbi.nlm.nih.gov/pubmed/35977355 (otvara se novi prozor)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (otvara se novi prozor)

Phan DL, Ani F, Schwarzkopf R.

Izvor‎: J Arthroplasty 2016;31(3):579-82.

Indeks‎: PubMed 26601635

DOI‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (otvara se novi prozor)

Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (otvara se novi prozor)

Pitta M, Zawadsky M, Verstraete R, Rubinstein A.

Izvor‎: Transfusion 2016;56(2):466-71.

Indeks‎: PubMed 26509250

DOI‎: 10.1111/trf.13354

https://www.ncbi.nlm.nih.gov/pubmed/26509250 (otvara se novi prozor)

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (otvara se novi prozor)

Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG.

Izvor‎: BMJ 2014;349:g4829.

Indeks‎: PubMed 25116268

DOI‎: 10.1136/bmj.g4829

https://www.ncbi.nlm.nih.gov/pubmed/25116268 (otvara se novi prozor)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (otvara se novi prozor)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

Izvor‎: Clin Orthop Relat Res 2010;468(7):1905-11.

Indeks‎: PubMed 20063079

DOI‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (otvara se novi prozor)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (otvara se novi prozor)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

Izvor‎: J Arthroplasty 2018;33(7):2092-9.e9.

Indeks‎: PubMed 29605152

DOI‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (otvara se novi prozor)

Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (otvara se novi prozor)

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG.

Izvor‎: Transfus Med 2009;19(4):202-6.

Indeks‎: PubMed 19706137

DOI‎: 10.1111/j.1365-3148.2009.00929.x

https://www.ncbi.nlm.nih.gov/pubmed/19706137 (otvara se novi prozor)

Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (otvara se novi prozor)

Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D'Amato T.

Izvor‎: Int Orthop 2019;43(1):39-46.

Indeks‎: PubMed 30232527

DOI‎: 10.1007/s00264-018-4149-7

https://www.ncbi.nlm.nih.gov/pubmed/30232527 (otvara se novi prozor)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (otvara se novi prozor)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Izvor‎: Int Orthop 2019;43(12):2707-14.

Indeks‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (otvara se novi prozor)

Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (otvara se novi prozor)

Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M.

Izvor‎: J Orthop Surg Res 2011;6:22.

Indeks‎: PubMed 21600028

DOI‎: 10.1186/1749-799X-6-22

https://www.ncbi.nlm.nih.gov/pubmed/21600028 (otvara se novi prozor)

Increased hospital costs associated with red blood cell transfusion. (otvara se novi prozor)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Izvor‎: Transfusion 2015;55(5):1082-9.

Indeks‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (otvara se novi prozor)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (otvara se novi prozor)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Izvor‎: J Arthroplasty 2014;29(8):1512-5.

Indeks‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (otvara se novi prozor)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (otvara se novi prozor)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

Izvor‎: J Arthroplasty 2020;35(11):3084-8.

Indeks‎: PubMed 32654943

DOI‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (otvara se novi prozor)

Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (otvara se novi prozor)

Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.

Izvor‎: Thromb Res 2018;171:143-8.

Indeks‎: PubMed 30312799

DOI‎: 10.1016/j.thromres.2018.10.006

https://www.ncbi.nlm.nih.gov/pubmed/30312799 (otvara se novi prozor)

Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. (otvara se novi prozor)

Ye X, Lafuma A, Torreton E, Arnaud A.

Izvor‎: BMC Health Serv Res 2013;13:186.

Indeks‎: PubMed 23692862

DOI‎: 10.1186/1472-6963-13-186

https://www.ncbi.nlm.nih.gov/pubmed/23692862 (otvara se novi prozor)

The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (otvara se novi prozor)

Zacharopoulos A, Apostolopoulos A, Kyriakidis A.

Izvor‎: Int Orthop 2007;31(3):303-8.

Indeks‎: PubMed 16810542

DOI‎: 10.1007/s00264-006-0173-0

https://www.ncbi.nlm.nih.gov/pubmed/16810542 (otvara se novi prozor)

Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. (otvara se novi prozor)

Zhu J, Zhu Y, Lei P, Zeng M, Su W, Hu Y.

Izvor‎: Medicine 2017;96(52):e9552.

Indeks‎: PubMed 29384974

DOI‎: 10.1097/MD.0000000000009552

https://www.ncbi.nlm.nih.gov/pubmed/29384974 (otvara se novi prozor)